X-linked vacuolated myopathy: TNF-α and IFN-γ expression in muscle fibers with MHC class I on sarcolemma

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 355-359

  Rouger, K ^a   Louboutin, J P ^a   Villanova, M ^a   Cherel, Y ^a   Fardeau, M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE BIOPSY; MYOPATHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; X CHROMOSOME LINKED DISORDER;

EID: 0035138540     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63976-4     Document Type: Article

References (21)

1. X-linked myopathy with excessive autophagy: A new hereditary muscle disease
2. X-linked vacuolated myopathy: Complement membrane attack complex on surface membrane of injured muscle fibers
3. Elevated levels of complement components C5 and C9 and decreased antitrypsin activity in the serum of patients with X-linked vacuolated myopathy
4. X-linked vacuolated myopathy: Membrane attack complex deposition on muscle fiber membranes with calcium accumulation on sarcolemma
5. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes
6. Induction of HLA-DR expression on human myoblasts with interferon-gamma
7. Synergy between interferon gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB
8. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaB beta degradation
9. NF-κB: Ten years after
10. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy non-weak controls
11. Polymyositis, dermatomyositis, inclusion-body myositis
12. Cytokine expression profile in idiopathic inflammatory myopathies
13. Idiopathic inflammatory myopathies: Inclusion body myositis, polymyositis, dermatomyositis
14. Increased expression of HLA A, B. C class I antigens in Duchenne muscular dystrophy, inflammatory myopathy, other neuromuscular disorders
15. Major histocompatibility complex I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies
16. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles
17. Down-regulation of transcription factors AP-1, Sp-1, NF-kappa B precedes myocyte differentiation
18. Glutathione regulation of tumor necrosis factor-α-induced NF-κ B activation in skeletal muscle-derived L6 cells
19. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkBa/NF-κ B pathway in limb-girdle muscular dystrophy type 1A
20. Signal transducer and activator of transcription 1 in human muscle: Implications in inflammatory myopathies
21. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-κB activation